Kilitch Drugs (India) Limited
NSE: KILITCH | Information Technology
Market Fundamentals
Stock Intelligence & News
Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Kilitch Drugs (India) Limited
Mukund mehta has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. |SUBJECT: Outcome of Board Meeting
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Kilitch Drugs (India) Limited
Board Meeting Intimation |Meeting Date: 15-May-2026
Read Full Analysis →Kilitch Drugs (India) Limited
KILITCH DRUGS (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 15-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Quarterly ended March 2026 . |SUBJECT: Board Meeting Intimation
Read Full Analysis →Kilitch Drugs (India) Limited
Financial Results |Meeting Date: 15-May-2026
Read Full Analysis →Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |SUBJECT: Certificate under SEBI (Depositories and Participants) Regulations, 2018
Read Full Analysis →Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on March 25, 2026. |SUBJECT: Outcome of Board Meeting
Read Full Analysis →Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis →Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →Get instant alerts when KILITCH breaks news
Join investors who track Kilitch Drugs (India) Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for KILITCH?
KILITCH is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Kilitch Drugs (India) Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding KILITCH to your custom watchlist.